The Valley Desk

ReviewAdvances in therapyPublished

Golimumab for the Treatment of Axial Spondyloarthritis: Integrating Clinical Outcomes with Real-World Patient Benefits

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Review
Venue
Advances in therapy
Published
Subject terms
Animals; Humans; Tumor Necrosis Factor-alpha; Antibodies, Monoclonal; Treatment Outcome; Quality of Life; Randomized Controlled Trials as Topic; Axial Spondyloarthritis; Safety; Quality of life; Golimumab; Drug Survival
PubMed ID
42573952
PubMed Central ID
PMC13748335
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal